Financial Ratios

NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private
BSE188.000 (0 %)
PREV CLOSE ( ) 188.00
OPEN PRICE ( ) 189.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3278
TODAY'S LOW / HIGH ( )186.90 191.80
52 WK LOW / HIGH ( )150.55 243.7
NSE187.65-0.1 (-0.05 %)
PREV CLOSE( ) 187.75
OPEN PRICE ( ) 187.70
BID PRICE (QTY) 187.65 (539)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19066
TODAY'S LOW / HIGH( ) 185.35 191.55
52 WK LOW / HIGH ( )150.4 244.6
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)18.50-35.4329.2926.5620.22
   CEPS(Rs)20.09-33.8130.7727.3320.99
   DPS(Rs)2.002.002.000.000.00
   Book NAV/Share(Rs)301.70285.19322.71293.42267.09
   Tax Rate(%)3.17-6.231.92-4.071.12
Margin Ratios
   Core EBITDA Margin(%)16.2613.3921.7119.5818.78
   EBIT Margin(%)15.44-18.9521.3319.7119.14
   Pre Tax Margin(%)12.05-22.7718.4517.3316.83
   PAT Margin (%)11.67-24.1918.1018.0416.64
   Cash Profit Margin (%)12.67-23.0819.0118.5617.27
Performance Ratios
   ROA(%)4.59-8.817.337.336.31
   ROE(%)6.31-11.669.519.487.87
   ROCE(%)7.09-7.829.789.248.28
   Asset Turnover(x)0.390.360.410.410.38
   Sales/Fixed Asset(x)1.121.041.161.090.97
   Working Capital/Sales(x)0.991.020.850.920.85
Efficiency Ratios
   Fixed Capital/Sales(x)0.890.960.870.921.03
   Receivable days110.76127.81128.40140.20150.21
   Inventory Days259.37292.83255.51234.52220.34
   Payable days744.291663.14-1472.04-528.37-634.43
Valuation Parameters
   PER(x)7.660.0010.245.1222.84
   PCE(x)7.05-6.319.754.9822.01
   Price/Book(x)0.470.750.930.461.73
   Yield(%)1.410.940.670.000.00
   EV/Net Sales(x)1.121.782.091.103.96
   EV/Core EBITDA(x)6.7912.639.375.4220.04
   EV/EBIT(x)7.23-9.379.785.5620.69
   EV/CE(x)0.420.670.810.421.41
   M Cap / Sales0.891.461.850.923.80
Growth Ratio
   Net Sales Growth(%)8.24-9.499.8921.2020.49
   Core EBITDA Growth(%)26.63-42.8320.8724.0510.25
   EBIT Growth(%)188.22-180.3818.9524.829.26
   PAT Growth(%)152.22-220.9810.2631.3530.64
   EPS Growth(%)152.22-220.9810.2631.3530.64
Financial Stability Ratios
   Total Debt/Equity(x)0.180.170.160.130.11
   Current Ratio(x)2.412.413.102.782.95
   Quick Ratio(x)1.451.271.791.581.83
   Interest Cover(x)4.56-4.967.408.298.30
   Total Debt/Mcap(x)0.390.230.180.270.07

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.